Celebrating Bipartisan Congressional Leadership on the Global Fund

Fiscal Year 2025 Investment Case

New Report: Global Fund Partnership Has Saved 65 Million Lives Since 2002

Report: Expanding the HIV Response to Drive Broad-Based Health Gains

Video: The Central Role of Health Systems in Pandemic Preparedness

Report: The Global Fund’s Unique Contribution to Universal Health Coverage and Stronger Health Systems Private Sector Calls on Congress to Prioritize Strong Investment in the Global Fund U.S. Bilateral Programs and the Global Fund: Partnering to Amplify Impact Why We Invest in International Assistance and Global Health
More News

The Global Fund to Fight AIDS, Tuberculosis and Malaria: A smart, lifesaving U.S. investment

decline in combined death rate from AIDS, TB and malaria

READ FULL INVESTMENT CASE

THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA

Is the world’s largest global health funder

Invests more than $5 billion a year in programs run by local experts and governments

Builds stronger health systems, health security and pandemic preparedness

Accelerates the end of the world’s deadliest infectious diseases

FEATURED

Ending AIDS

Translating Progress into Success to End the AIDS Epidemic is a collaboration between amfAR, AVAC, and Friends of the Global Fight, with technical assistance from the Henry J. Kaiser Family Foundation. The report was conceptualized to take stock of how far we have come – and how far we have to go – toward ending HIV and AIDS around the world.

Ending TB

TB is curable. We need renewed and sustained political will to combat this epidemic. We know we can end the TB epidemic. It is a matter of scaling up effective programs, dedicating sufficient resources and mobilizing the political will. This report highlights six locations where communities made impressive progress to significantly reduce TB cases and deaths – from California in the United States to Tomsk, Russia and Karachi, Pakistan.

Ending Malaria

In the last two decades, global efforts against malaria have reached a tipping point, allowing health leaders for the first time to move beyond merely controlling this ancient disease and instead commit to ending it.

RECENT NEWS

The Global Fund: An Investment in U.S. Diplomatic and Security Interests

The Global Fund: An Investment in U.S. Diplomatic and Security Interests Backed by Military and Faith Leaders and the Private Sector Our new issue brief highlights how U.S. investments in the Global Fund deliver significant economic returns, strengthen diplomatic relations and advance national security interests.

Market Shaping: How the Global Fund is Saving Lives and Delivering on the Future of Health

As the largest financier of HIV, TB and malaria programs in low- and middle-income countries, the Global Fund leverages its scale to secure improved supply terms, ensure supply reliability and foster innovations that are accessible to all. These market shaping interventions make health products more affordable and accessible in low- and middle-income countries. Our new slide deck…

Friends Welcomes Dr. Raj Panjabi to Its Board of Directors 

Friends Welcomes Dr. Raj Panjabi to Its Board of Directors  Friends is thrilled to announce that Dr. Raj Panjabi has joined its Board of Directors. Dr. Panjabi is currently Senior Partner at Flagship Pioneering and on the faculty at Harvard Medical School and Brigham and Women’s Hospital. Among his many other roles, he previously led the U.S. President’s Malaria Initiative. In that position,…

Friends Board Member Receives Prestigious Lasker-Bloomberg Award for HIV Leadership

Friends Board Member Receives Prestigious Lasker-Bloomberg Award for HIV Leadership Washington, DC – Friends board member Dr. Quarraisha Abdool Karim has been honored with the Lasker-Bloomberg Public Service Award for her contribution to combating the spread of HIV/AIDS and for transformative public health advocacy and programming throughout Africa and globally. She received the award alongside…

READ MORE